Signature Diagnostics Appoints Rainer Kramer to Chief Business Officer and Member of the Management Board
Dr. Kramer holds a Diploma in Molecular Biology and a Ph.D from the Max-Planck-Institute for Neurobiology. Throughout his career in corporate business development, he contributed or delivered numerous strategic partnerships and license deals encompassing technology platform and product deals as well as equity transactions with an aggregate value of several hundred million Euros. As a member of Jerini's M&A committee, he was instrumental in the sale of Jerini to Shire in 2008 and was Shire's appointed principal for the sale of JPT GmbH in 2009.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.